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Molecular Determinants of effective Pore Formation
Antje Brack, Markus Schwiering, Christian Beck, Max Koistinen,
Heinz Decker, Nadja Hellmann.
Institute for Molecular Biophysics, Mainz, Germany.
Although the alpha-toxin from S. aureus was the first pore-forming toxin iden-
tified, its mode of interaction with membranes is still not fully understood. The
toxin forms heptameric pores on cellular and artificial membranes. The obser-
vation that artificial membranes are permeabelized by this toxin indicates that
no protein receptor is mandatory. Efficient permeabilisation is only possible in
presence of cholesterol and sphingomyelin, which could be interpreted as
a preference of the toxin for raft-like structures. However, variation of lipid
composition and determination of oligomer formation by pyrene-fluorescence
reveals, that the toxin favors specifically sphingomyelin in combination with
cholesterol and that the interaction is not raft-specific in a general sense. The
mode of action seems also to differ from the primary binding of the toxin lyse-
nin, which binds specifically to sphingomyelin.
Under certain conditions also non-lytic oligomers can be formed, for example
at low temperatures or for certain mutants. The spectra obtained for pyrene-
labelled mutants indicate that also lipid-composition might modulate the prob-
ability of lytic versus non-lytic pore formation, which might give a hint why for
some cell non-lytic cells are found.
Employing both AFM and fluorescence microscopy we aim to determine
the molecular basis for efficient pore formation by this toxin. We thank the
DFG (SFB 490) for financial support, S.Bhakdi and A.Valeva for production
of the toxin and helpful discussions, G. Gimpl for help with fluorescence mi-
croscopy and the MPI for Polymer Research for the possibility to use the AFM.
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Polycation Peptides Derived from the Primary Structure of Bacillus
thuringiensis Cry11Bb Protoxin Permeabilize Aedes aegypti Midgut
Mitochondria
Victor V. Lemeshko1, Gabriela Jaramillo2, Sergio Orduz1.
1Universidad Nacional de Colombia, Sede Medellin, Colombia,
2Corporacio´n para Investigaciones Biolo´gicas, Medellin, Colombia.
Cry toxins are highly active against dipteran insects, such as Aedes aegypti, but
not against mammals, thus representing a base for development of environmen-
tally safe insecticidal technologies. Earlier we demonstrated that BTM-P1, a
26 aa polycation peptide derived from domain I of the Cry11Bb protoxin, per-
meabilizes rat liver mitochondria and kill bacteria. In this work, we evaluated
its capacity to permeabilize the inner membrane of A. aegypti larvae midgut mi-
tochondria. The change in potential-dependent NAD(P)H fluorescence of the
midgut homogenate was used as criteria of mitochondria permeabilization.
When succinate was added, some increase in fluorescence intensity was ob-
served, related to reverse electron transport. Addition of a known membrane
protonophore FCCP caused a significant decrease in fluorescence intensity
that can be completely recovered after subsequent addition of cyanide. A sim-
ilar effect was observed by adding BTM-P1 or larger peptides BTM-P2 (37 aa)
and BTM-P3 (60 aa) at concentrations of 1 uM, or even with the addition of
natural hydrolysates of Cry11Bb obtained after treatment with larvae midgut
homogenate. Cry11Bb trypsin hydrolysate was ineffective. Fast oxidation of
endogenous NAD(P)H, mitochondrial swelling and inner membrane potential
drop were observed after addition of the peptides to isolated rat liver mitochon-
dria.We suggest that, in addition to the binding of Cry toxins to the corresponding
midgut receptors, the subsequent natural proteolysis of domain I might produce
various polycation peptides that cause permeabilization of the plasma and mito-
chondrial membranes by a potential-dependent manner that should be favored by
the lumen positive transepithelial potential of the posterior midgut. This workwas
supported by Colciencias grants #2213-12-17833 and #111840820380.
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Phosphatidylserine Selective Peptides As Novel Anti-cancer Agents
Yasemin Manavbasi1, Dagmar Zweytick1, Regine Willumeit2,
Karl Lohner1.
1Austrian Academy of Sciences, Graz, Austria, 2GKKS, Geesthacht,
Germany.
Antimicrobial peptides have gained interest as potential anti-cancer agents.
Phosphatidylserine (PS), which normally resides in the inner leaflet of the
plasma membrane, can move to the outer leaflet and act as a surface marker
of cancer cells. The surface exposure of negatively charged PS on prostate
tumour cells makes these cells susceptible to killing by cationic membranolytic
peptides such as NK-2 [1]. Shai et al. [2] have also shown the inhibition of
tumor growth in human prostate xenografts by host defense like lytic peptides.The aim of this study is to develop short peptide sequences acting selectively
towards PS exposed on cancer cells. As a prerequisite it is necessary to analyze
the lipid composition of prostate cancer cell - and non cancer cell plasma mem-
branes. Further as a basis for peptide activity studies the biophysical character-
istics of cancer cell membranes and healthy counterparts with respect to lipid
composition were determined by DSC and X-ray studies with liposomal
mimics. Fluorescence spectroscopy was applied to test the release of marker
molecules from liposomes, which revealed that some NK-2 derived peptides
have a high affinity towards PS.
Results of the in-vitro testing of optimized peptides on prostate cancer cell lines
together with biophysical data help us to shed light on the future evaluation of
their usage as anticancer therapeutics.
[1] Schro¨der-Borm H. et al., FEBS Lett. 579 (2005) 6128-61.
[2] Shai Y. et al., Cancer Research 2006; 66 (10) May 15.
Acknowledgement: Marie Curie Actions ‘‘Biocontrol’’.
812-Pos Board B691
Human Erythrocytes And Mononuclear Leukocytes Are Capable Of
Concentrating HIV-1 Fusion Inhibitor Peptides In Their Membranes
Pedro M. Matos1,2, Miguel A.R.B. Castanho1,2, Nuno C. Santos1,2.
1Instituto de Medicina Molecular, Lisboa, Portugal, 2Faculdade de Medicina
da Universidade de Lisboa, Lisboa, Portugal.
Following the successful approval of the first HIV-1 fusion inhibitor, enfuvir-
tide (formerly T-20), T-1249 was developed to be one of the next generation
drug of this type. Previous studies, based on tryptophan intrinsic fluorescence,
showed that these peptides interact with membrane model systems (large uni-
lamellar vesicles) of different lipid compositions. Studies with human blood
cell membranes were necessary to further establish the role of membranes on
these peptides mode of action. An experimental strategy was applied taking
into account the membrane dipole potential as measured by the potential sen-
sitive fluorescent probe di-8-ANEPPS. Successful labelling was performed
with erythrocytes and peripheral blood mononuclear cells (PBMC) isolated
from human blood samples.
For erythrocytes, membrane bound di-8-ANEPPS excitation spectra were blue
shifted, indicating a decrease in the dipole potential due to peptide-membrane in-
teractions. Accordingly, a decrease in the probe fluorescence excitation ratio (a
measure of the spectral shift) dependent of peptide concentration was observed.
The quantitative analysis of these variations indicated that T-1249 had the higher
affinity towards erythrocytemembrane. This is in agreement with the previously
known adsorption of this peptide on cholesterol-rich membrane domains.
Preliminary results show that the behaviour is similar in the case of PBMC,
with a decrease in dipole potential that is more pronounced for T-1249. As there
is strong suggestion that HIV also associates with erythrocytes in vivo, the pep-
tide concentration effect of the erythrocytes and lymphocyte membranes can
correlate with the stronger efficacy of T-1249.
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Membrane Interaction of N-Terminal Peptides of Annexin A1
Heiko Weigelt, Olaf Zscho¨rnig.
University of Leipzig, Leipzig, Germany.
Annexin A1 is a member of a family of calcium-dependent membrane-binding
proteins. This protein is known for its anti-inflammatory effect and for its abil-
ity to aggregate phospholipid membranes. A N-terminal annexin A1 peptide ac-
tivates and desensitizes the human N-formyl peptide receptor (FPR), a member
of G-protein coupled receptors that is a key modulator of chemotaxis directing
granulocytes toward sites of bacterial infections. The N-terminal domain of
annexin A1 mainly seems to be responsible for the biological activities of
this protein. So we are interested in the (Ca2þ-independent) membrane binding
activities and structural information of the phospholipid membrane interaction
of N-terminal peptides of annexin A1.
We investigated the membrane interaction of synthesized N-terminal peptides
of annexin A1 (residues Ac2-26 and 1-40) with artificial vesicles of different
lipid compositions (mainly phosphatidylserine and phosphatidylcholine) and
under varying buffer conditions (ionic strength, pH of the solution) by using
fluorescence techniques. For these measurements we used the A1NT peptide
labelled at 4 different positions with a dansyl fluorophore. From the experimen-
tally measured binding curves the Gibbs free energy for the peptide transfer
from aqueous solution to the lipid membrane was calculated. The effective
charge of the peptide depends on the pH value of the buffer and is about half
of its theoretical net charge. Fluorescence correlation spectroscopy measure-
ments were done with TAMRA labelled A1NT peptide and giant unilamellar
vesicles. The binding of fluorescently labelled peptides to micro-domains (lipid
rafts) in differently compounded giant vesicles we observed using confocal la-
ser scanning microscopy. Structural information of membrane bound peptide
we reached by polarized infrared spectroscopy (ATR-FTIR). Further, the
position of A1NT a-helix in the membrane was estimated from the intrinsic
